Hyphens Pharma launches treatment for Atopic dermatitis (Eczema) expanding it’s Ceradan® series
Generics | News | 0 Comment | 19 Sep, 2024
Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, ...Read more
Addressing Supply Chain Vulnerabilities in the Global Pharmaceutical Industry
Generics | News | 0 Comment | 22 Aug, 2024
Industries with international operations face increasing vulnerability to supply chain disruptions. This risk is particu...Read more
Chinese generic drug for breast, pancreatic, and lung cancer approved in EU market
Generics | News | 0 Comment | 31 Jul, 2024
Apexelsin, a generic drug from China been approved by the European Commission. Apexelsin is a generic dru...Read more
Generics | News | 0 Comment | 07 Mar, 2024
The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...Read more
Generics | News | 0 Comment | 01 Dec, 2023
The third edition of the "Asia Pacific Forum on Precision Cancer Treatment" concluded today with a dynamic exchange of i...Read more
Generics | Opinion | 0 Comment | 04 Jul, 2023
How did the company perform during FY 2022-23? The company is currently in a recovery phase following the impact ...Read more
Generic manufacturers from India & Indonesia bring affordable drug for cancer treatment
Generics | News | 1 Comment | 23 Jun, 2023
The Medicines Patent Pool (MPP), a United Nations-backed public health organisation, has signed sublicence agreemen...Read more
Australia-based Mayne Pharma sells US generic prescription product portfolio for $90 M
Generics | News | 0 Comment | 28 Feb, 2023
Dr. Reddy's Laboratories SA, a wholly-owned subsidiary of Indian pharmaceutical company Dr. Reddy’s Laboratories, ...Read more
Indian pharma firm Venus Remedies gets marketing approval for cancer drugs in Uzbekistan, Palestine
Generics | News | 0 Comment | 23 Feb, 2023
Indian pharmaceutical company Venus Remedies has received marketing authorisation for its generic cancer drugs from Uzbe...Read more
ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist
Generics | News | 0 Comment | 28 Sep, 2022
Trans-Atlantic private equity healthcare specialist ArchiMed has invested in Bielefeld, Germany-based PlasmidFactory. Fo...Read more
Generics | News | 0 Comment | 08 Aug, 2022
Pharmaceutical companies need to ensure they have a competitive edge in the market while adapting to evolving industry b...Read more
35 manufacturers sign agreements to produce generic versions of Pfizer's oral COVID-19 drug
Generics | News | 0 Comment | 18 Mar, 2022
The Medicines Patent Pool (MPP) has signed agreements with 35 companies to manufacture the generic version of Pfizer's o...Read more
Taiwan approves new first-line treatment for advanced renal cell carcinoma
Generics | News | 0 Comment | 31 Jan, 2022
Eisai Co. has announced that LENVIMA (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase inh...Read more
Eisai to market Gilead’s rheumatoid arthritis drug in Asia
Generics | News | 0 Comment | 23 Dec, 2021
Japanese firm Eisai has entered into an agreement with Gilead Sciences, Inc. for the commercialisation and distribution ...Read more
Biocon partners with Tabuk Pharma to commercialise speciality generic medicines in Middle East
Generics | News | 0 Comment | 08 Dec, 2021
Indian firm Biocon has announced a partnership with Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary...Read more
C2 PHARMA Completes Multiple Local Regulatory Filings and Expands Portfolio
Generics | News | 0 Comment | 10 Nov, 2021
Multiple regulatory filings have been submitted to expand distribution channels globally across China, Taiwan, South Kor...Read more
Patient access to gene therapies for cancer set to increase in next decade: GlobalData
Generics | News | 0 Comment | 25 Jun, 2021
Gene therapies will provide a valid treatment option for patients that have developed resistance to chemotherapies acros...Read more
Bayer leads Metagenomi complete $65M series A financing round
Generics | News | 0 Comment | 16 Nov, 2020
US-based Metagenomi, a next generation gene editing company launched by UC Berkeley scientists in 2018, successfully com...Read more